Case Reports in Infectious Diseases

Case Reports in Infectious Diseases / 2013 / Article

Case Report | Open Access

Volume 2013 |Article ID 528795 | 5 pages | https://doi.org/10.1155/2013/528795

Atypical Osteomyelitis Caused by Mycobacterium chelonae—A Multimodal Imaging Approach

Academic Editor: J.-F. Faucher
Received02 Feb 2013
Accepted12 Mar 2013
Published31 Mar 2013

Abstract

We present an unusual case of a biopsy-proven Mycobacterium chelonae infection (MCI) of skin and soft tissue, which led to osteomyelitis in a 55-year-old Caucasian male. We provide clinical data and discussion about MCI and its diagnostic workup and demonstrate comprehensive imaging findings, including clinical pictures, radiographs, three-phase bone scintigraphy, and combined SPECT/CT findings of this entity, which have not yet been presented in the medical literature.

1. Introduction

Mycobacterium chelonae is an atypical mycobacterium which does not cause tuberculosis or leprosy in humans. They are known for infections of skin, lungs, eyes, and soft tissue. People with immunodeficiency are more likely to contract an infection although a minority of concerned patients were reported to be primary healthy. The identification of the agent is performed by bacterial cultures, polymerase chain reaction (PCR), and DNA sequencing [1].

Bone and joint infections are extremely rare in the context of atypical mycobacterium infections [2].

Osteomyelitis is mostly caused by staphylococcus aureus (75–80%), infrequently also by other bacteria, viruses, and funguses [2, 3].

In the medical literature we found only 2 cases of Mycobacterium chelonae osteomyelitis visualized by multiple diagnostic imaging modalities [2, 4]. To our best knowledge SPECT/CT findings have not yet been published at all.

2. Clinical Presentation

The patient is a 55-year-old Caucasian male with an unclear redness and swelling at the right medial malleolus without any noticed trauma. His medical record includes ulcerative colitis and sarcoidosis treated with prolonged cortisone therapy and liver transplant for treatment of primary sclerosing cholangitis (PSC) 14 years ago.

Tentative diagnosis was gout because of high uric acid in blood testing but common ambulant drug therapy with colchicine and indomethacin did not improve the condition. Spreading of the swelling and redness in combination with increasing inflammation parameters was interpreted as possible phlegmon and treated with penicillin. However no regression was observed and the patient developed additional nodular lesions spreading from the ankle to the anterior medial lower leg. Visible were 12–15 nodular lesions, the newest and proximal lesions were erythematous, and the older ones were darker and violaceous with some scaling (Figure 1).

In the following, punch biopsies were performed, which microscopically showed positive results on gram staining and acid resistance on Ziehl-Neelsen staining, matching with mycobacteria. Bacteria cultures revealed rapidly growing mycobacteria of Runyon group IV.

Additional PCR and sequencing of the amplified DNA detected Mycobacterium chelonae.

In the course of the events several diagnostic imaging modalities were conducted to find out about a possible osseous involvement, which is important for the appropriate selection of antibiotics.

Initially radiographs of the right ankle, tibia, and fibula were obtained, showing moderate circumferential soft tissue swelling around the metatarsophalangeal joint I (MTP I). The ankle mortise was intact with the underlying bony structures appearing normal, beside a healed fracture at the proximal first phalanx (Figure 2).

For further investigation MRI was scheduled but even with sedation refused by the patient due to claustrophobia.

Instead a three-phase bone scan (33 mCi Tc-99 m MDP IV with 24-hour delay) was performed which showed local hyperemia at the right distal lower leg and the MTP I on perfusion phase, surrounding soft tissue tracer uptake on blood pool phase and increased bone remodeling on bone phase, also at the right distal lower leg and the MTP I (Figure 3, bone phase).

Subsequently, using the already given tracer, a combined SPECT/CT was conducted which provides the advantages of better localization and demonstration of morphological changes, compared with scintigraphy.

In the merged pictures we could localize the increased tracer uptake exactly at the distal tibia and the MTP I (Figure 4). The CT data showed evidence of soft tissue and periosteal reaction and osseous disruption at the MTP I (Figure 5).

The combination of findings was indicative for a soft tissue infection with additional multifocal osteomyelitis, at the MTP I already with initial osseous destructions.

Antibiotic therapy was adjusted, following antibiogram, to a combination of azithromycin, moxifloxacin, and meropenem under which the patient improved. He could be discharged from our hospital in a good condition 2 weeks later.

3. Discussion

Mycobacteria are a heterogeneous group of aerobic bacteria. There are significant differences in the appropriate treatment so that it is important to distinguish between the agents.

The group can be detected by being gram positive and acid-fast on gram and Ziehl-Neelsen staining. The Runyon classification divides into 4 groups, based on growth rates in bacterial cultures. PCR and DNA sequencing are helpful to detect the agent.

The most familiar mycobacteria are Mycobacterium tuberculosis and Mycobacterium leprae, both listed in Runyon Group III.

Mycobacterium chelonae is a rapidly growing species (Runyon group IV) of mycobacteria other than tuberculosis (MOTT). Those do not respond to first-line antituberculosis drugs.

It is found in natural and processed water sources and known to be responsible for a distinct number of primary infections of the skin, lung, eyes, and soft tissue [2, 57].

As an opportunistic pathogen it should be considered when unclear skin and soft tissue infections occur on immunosuppressed patients like patients on corticosteroid therapy, after organ transplantation and with immunodeficiency or autoimmune disorders.

Infections of the bone and joints by nontuberculous mycobacteria, such as Mycobacterium chelonae, are extremely rare and often overlooked with less than a dozen reported cases in the medical literature [2, 8]. However for the selection of antibiotic therapy and for avoidance of chronification, it is of high priority to be aware of possible bone affection.

The disease is often a disseminated cutaneous infection [9, 10], like in our case. If osteomyelitis takes place in this regard, it is usually localized [9, 11] with only one reported case of multifocal osseous involvement [2]. Our findings are indicative for bifocal affection of the distal tibia and the MTP I.

Osteomyelitis by Mycobacterium chelonae has occurred occasionally in the sternum after cardiac operations [12, 13] or in immunocompromised patients [8, 10, 14, 15]; however recent publications reported also occurrence in previously healthy patients [4, 6]. Sternal osteomyelitis is associated with a poor clinical prognosis, perhaps related to late diagnosis and consecutive late onset of specific treatment [12].

To our best knowledge only 2 manuscripts have been published, describing Mycobacterium chelonae osteomyelitis on imaging [2, 4]. So far no literature has been published, describing SPECT/CT imaging findings of osteomyelitis caused by atypical mycobacteria, especially by Mycobacterium chelonae.

All previous reports demonstrated advanced bone changes on imaging, already visible on X-ray. In our case, the initial radiograph was unremarkable for osteomyelitis but we were able to detect the infection with MDP bone scan and get information about localization and morphological changes with a combined SPECT/CT, facilitating appropriate antibiotic therapy.

Conflict of Interests

The authors declare that they have no conflict of interests.

References

  1. J. M. Lim, J. H. Kim, and H. J. Yang, “Management of infections with rapidly growing mycobacteria after unexpected complications of skin and subcutaneous surgical procedures,” Archives of Plastic Surgery, vol. 39, no. 1, pp. 18–24, 2012. View at: Publisher Site | Google Scholar
  2. D. S. Korres, P. J. Papagelopoulos, K. A. Zahos, M. D. Kolia, G. G. Poulakou, and M. E. Falagas, “Multifocal spinal and extra-spinal Mycobacterium chelonae osteomyelitis in a renal transplant recipient,” Transplant Infectious Disease, vol. 9, no. 1, pp. 62–65, 2007. View at: Publisher Site | Google Scholar
  3. A. Widaa, T. Claro, T. J. Foster, F. J. O'Brien, and S. W. Kerrigan, “Staphylococcus aureus protein A plays a critical role in mediating bone destruction and bone loss in osteomyelitis,” PLoS One, vol. 7, no. 7, Article ID e40586, 2012. View at: Google Scholar
  4. R. S. Kim, J. S. Kim, D. H. Choi, D. S. Kwon, and J. H. Jung, “M. chelonae soft tissue infection spreading to osteomyelitis,” Yonsei Medical Journal, vol. 45, no. 1, pp. 169–173, 2004. View at: Google Scholar
  5. A. M. Hernandez Garcia, A. Arias, A. Felipe, R. Alvarez, and A. Sierra, “Determination of the in vitro susceptibility of 220 Mycobacterium fortuitum isolates to ten antimicrobial agents,” Journal of Chemotherapy, vol. 7, no. 6, pp. 503–508, 1995. View at: Google Scholar
  6. H. Gollwitzer, R. Langer, P. Diehl, and W. Mittelmeier, “Chronic osteomyelitis due to Mycobacterium chelonae diagnosed by polymerase chain reaction homology matching: a case report,” Journal of Bone and Joint Surgery A, vol. 86, no. 6, pp. 1296–1301, 2004. View at: Google Scholar
  7. S. M. Cook, R. E. Bartos, C. L. Pierson, and T. S. Frank, “Detection and characterization of atypical mycobacteria by the polymerase chain reaction,” Diagnostic Molecular Pathology, vol. 3, no. 1, pp. 53–58, 1994. View at: Google Scholar
  8. V. Roy and D. Weisdorf, “Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review,” Bone Marrow Transplantation, vol. 19, no. 5, pp. 467–470, 1997. View at: Google Scholar
  9. S. Sungkanuparph, B. Sathapatayavongs, and R. Pracharktam, “Infections with rapidly growing mycobacteria: report of 20 cases,” International Journal of Infectious Diseases, vol. 7, no. 3, pp. 198–205, 2003. View at: Publisher Site | Google Scholar
  10. R. J. Wallace Jr., B. A. Brown, and G. O. Onyi, “Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin,” Journal of Infectious Diseases, vol. 166, no. 2, pp. 405–412, 1992. View at: Google Scholar
  11. N. J. Suttner, Z. Adhami, and A. R. Aspoas, “Mycobacterium chelonae lumbar spinal infection,” British Journal of Neurosurgery, vol. 15, no. 3, pp. 265–269, 2001. View at: Publisher Site | Google Scholar
  12. F. Robicsek, P. C. Hoffman, T. N. Masters et al., “Rapidly growing nontuberculous mycobacteria: a new enemy of the cardiac surgeon,” Annals of Thoracic Surgery, vol. 46, no. 6, pp. 703–710, 1988. View at: Google Scholar
  13. L. E. Samuels, S. Sharma, R. J. Morris et al., “Mycobacterium fortuitum infection of the sternum: review of the literature and case illustration,” Archives of Surgery, vol. 131, no. 12, pp. 1344–1346, 1996. View at: Google Scholar
  14. T. C. Pruitt, L. O. Hughes, R. D. Blasier, R. E. McCarthy, C. M. Glasier, and G. J. Roloson, “Atypical mycobacterial vertebral osteomyelitis in a steroid-dependent adolescent: a case report,” Spine, vol. 18, no. 16, pp. 2553–2555, 1993. View at: Google Scholar
  15. S. Wilson, B. Cascio, and H. R. Neitzschman, “Radiology case of the month. Nail puncture wound to the foot. Mycobacterium chelonei osteomyelitis,” The Journal of the Louisiana State Medical Society, vol. 151, no. 5, pp. 251–252, 1999. View at: Google Scholar

Copyright © 2013 Roland Talanow et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

2672 Views | 687 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.